CD68 antibody | FA-11

100% Secure


Rat anti Mouse CD68:Alexa Fluor® 488

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:Alexa Fluor® 647

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:Biotin

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:FITC

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:Endotoxin Low

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:RPE

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:Alexa Fluor® 700

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Rat anti Mouse CD68:Amethyst Orange

CD68 antibody, clone FA-11 recognizes mouse macrosialin which is a homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member. CD68 is considered a pan macrophage marker expressed on the intracellular lysosomes of tissue macrophages.

Product Type
Monoclonal Antibody
Clone
FA-11
Isotype
IgG2a
Product Code Applications Pack Size List Price Quantity
MCA1957A488
Datasheet
F*
SDS
100 Tests/1ml loader

MCA1957A488T
Datasheet
F*
SDS
25 Tests/0.25ml loader

MCA1957A647
Datasheet
F*
SDS
100 Tests/1ml loader

MCA1957A647T
Datasheet
F*
SDS
25 Tests/0.25ml loader

MCA1957B
Datasheet
C F
SDS
0.1 mg loader

MCA1957BT
Datasheet
C F
SDS
25 µg loader

MCA1957F
Datasheet
F*
SDS
0.1 mg loader

MCA1957FA
Datasheet
F*
SDS
50 µg loader

MCA1957FT
Datasheet
F*
SDS
25 µg loader

MCA1957EL
Datasheet
C F* IF IP P* WB*
SDS
0.5 mg loader

MCA1957
Datasheet
C F* IF IP P* WB*
SDS
0.25 mg loader

MCA1957T
Datasheet
C F* IF IP P* WB*
SDS
25 µg loader

MCA1957GA
Datasheet
C F* IF IP P* WB*
SDS
0.1 mg loader

MCA1957PE
Datasheet
F*
SDS
100 Tests loader

MCA1957PET
Datasheet
F*
SDS
25 Tests loader

MCA1957A700
Datasheet
F*
SDS
100 Tests/1ml loader

MCA1957A700T
Datasheet
F*
SDS
25 Tests/0.25ml loader

MCA1957AMO
Datasheet
F*
SDS
0.1 mg loader

Rat anti Mouse CD68 antibody, clone FA-11 recognizes mouse macrosialin, a heavily glycosylated transmembrane protein and murine homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member, due to the presence of a lysosome associated membrane protein (LAMP)-like domain.

CD68 is considered a pan macrophage marker, predominantly expressed on the intracellular lysosomes of tissue macrophages/monocytes, including Kupffer cells, microglia, histiocytes and osteoclasts, and is expressed to a lesser extent by dendritic cells and peripheral blood granulocytes.

CD68 is expressed by many tumor types including some B cell lymphomas, blastic NK lymphomas, melanomas, granulocytic (myeloid) sarcomas, hairy cell leukemias, and renal, urinary and pancreatic tumors, and can be used in cancer studies to demonstrate the presence/localization of macrophages.

Rat anti mouse CD68 antibody, clone FA-11, has been used in many mouse models for the identification of CD68 in immunohistochemical studies, using both frozen and paraffin-embedded tissues (Masaki et al. 2003) and (Devey et al. 2009).

Rat anti mouse CD68 antibody, clone FA-11 can be used in flow cytometry to detect intracellular CD68, following permeabilization, and can detect surface macrosialin at low levels in resident mouse peritoneal macrophages which can be enhanced with thioglycollate stimulation.

Product Details

Target Species
Mouse
Product Form
Purified IgG conjugated to Alexa Fluor® 488 - liquid
Product Form
Purified IgG conjugated to Alexa Fluor® 647 - liquid
Product Form
Purified IgG conjugated to Biotin - liquid
Product Form
Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
Product Form
Purified IgG - liquid
Product Form
Purified IgG - liquid
Product Form
Purified IgG conjugated to R. Phycoerythrin (RPE) - lyophilized
Product Form
Purified IgG conjugated to Alexa Fluor® 700 - liquid
Product Form
Purified IgG conjugated to Amethyst Orange - liquid
Reconstitution
Pack Size: 100 Tests
Reconstitute with 1.0 ml distilled water
Pack Size: 25 Tests
Reconstitute in 0.25 ml disilled water
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
None present
Preservative Stabilisers
0.09%Sodium Azide
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
5%Sucrose
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09% Sodium Azide (NaN3)
1% Bovine Serum Albumin
Carrier Free
Yes
Carrier Free
Yes
Immunogen
Purified Concanavalin A acceptor glycoprotein from P815 cell line.
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Approx. Protein Concentrations
IgG concentration 0.1mg/ml
Approx. Protein Concentrations
IgG concentration 0.1mg/ml
Approx. Protein Concentrations
IgG concentration 1.0mg/ml
Approx. Protein Concentrations
Pack Size: 0.25 mg, 25 µg
IgG concentration 1.0mg/ml
Pack Size: 0.1 mg
IgG concentration 1.0 mg/ml
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Approx. Protein Concentrations
IgG concentration 0.1 mg/ml

Storage Information

Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
Storage
Store at -20oC only.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Storage
Store at +4oC.

DO NOT FREEZE.

This product should be stored undiluted. This product is photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
Storage
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch

More Information

UniProt
P31996
Entrez Gene
Cd68
GO Terms
GO:0005886 plasma membrane
GO:0016021 integral to membrane
GO:0005765 lysosomal membrane
GO:0010008 endosome membrane
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Regulatory
For research purposes only

Applications of CD68 antibody

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
Flow Cytometry 1 Neat 1/10
Flow Cytometry 1 Neat 1/10
Flow Cytometry
Immunohistology - Frozen 1/10
Flow Cytometry 1 Neat 1/10
Flow Cytometry 1 1/50 1/100
Immunofluorescence
Immunohistology - Frozen
Immunohistology - Paraffin 2
Immunoprecipitation
Western Blotting 3
Flow Cytometry 1 1/50 1/100
Immunofluorescence
Immunohistology - Frozen
Immunohistology - Paraffin 2
Immunoprecipitation
Western Blotting 3
Flow Cytometry 1 Neat
Flow Cytometry 1 Neat 1/10
Flow Cytometry 1 Neat 1/10
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041)
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041A)
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041).
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  2. 2This product may require antigen retrieval using heat treatment prior to staining of paraffin sections.Sodium citrate buffer pH 6.0 is recommended for this purpose. See Martin-Manso for details. Staining has also been achieved without antigen retrieval, see Lu for details.
  3. 3 Non-reducing conditions recommended.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  2. 2This product may require antigen retrieval using heat treatment prior to staining of paraffin sections. Either sodium citrate buffer or Tris/EDTA buffer may be used for this purpose. See Martin-Manso for details. Staining has also been achieved without antigen retrieval, see Lu for details.
  3. 3 Non-reducing conditions recommended.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041).
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041).
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
    The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors. This may be reduced by using SeroBlock FcR (Product Code BUF041)
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Recommended protocols are available Here

Secondary Antibodies Available

Description Product Code Applications Pack Size List Price Quantity
Goat anti Rat IgG:Alk. Phos. (Mouse Adsorbed) STAR131A C E P WB 1 ml loader
Goat anti Rat IgG:Biotin (Mouse Adsorbed) STAR131B C E IF P WB 0.5 mg loader
Rabbit F(ab')2 anti Rat IgG:Dylight®800 STAR16D800GA F IF WB 0.1 mg loader
Rabbit F(ab')2 anti Rat IgG:FITC STAR17B F 1 mg loader
Rabbit F(ab')2 anti Rat IgG:HRP STAR21B C E P RE 1 mg loader
Goat F(ab')2 anti Rat IgG:FITC (Mouse Adsorbed) STAR69 F 0.5 ml loader
Goat anti Rat IgG:DyLight®650 (Mouse Adsorbed) STAR71D650 F IF 0.1 mg loader
Goat anti Rat IgG:Dylight®800 (Mouse Adsorbed) STAR71D800GA F IF WB 0.1 mg loader
Goat anti Rat IgG:HRP (Mouse Adsorbed) STAR72 C E P 0.5 mg loader
Goat F(ab')2 anti Rat IgG:RPE (Mouse Adsorbed) STAR73 F 0.5 ml loader
Goat anti Rat IgG:Alk. Phos. (Mouse Adsorbed) STAR131A C E P WB 1 ml loader
Goat anti Rat IgG:Biotin (Mouse Adsorbed) STAR131B C E IF P WB 0.5 mg loader
Rabbit F(ab')2 anti Rat IgG:Dylight®800 STAR16D800GA F IF WB 0.1 mg loader
Rabbit F(ab')2 anti Rat IgG:FITC STAR17B F 1 mg loader
Rabbit F(ab')2 anti Rat IgG:HRP STAR21B C E P RE 1 mg loader
Goat F(ab')2 anti Rat IgG:FITC (Mouse Adsorbed) STAR69 F 0.5 ml loader
Goat anti Rat IgG:DyLight®650 (Mouse Adsorbed) STAR71D650 F IF 0.1 mg loader
Goat anti Rat IgG:Dylight®800 (Mouse Adsorbed) STAR71D800GA F IF WB 0.1 mg loader
Goat anti Rat IgG:HRP (Mouse Adsorbed) STAR72 C E P 0.5 mg loader
Goat F(ab')2 anti Rat IgG:RPE (Mouse Adsorbed) STAR73 F 0.5 ml loader

Negative Isotype Controls Available

Description Product Code Applications Pack Size List Price Quantity
Rat IgG2a Negative Control:Alexa Fluor® 488 MCA1212A488 F 100 Tests/1ml loader
Rat IgG2a Negative Control:Alexa Fluor® 647 MCA1212A647 F 100 Tests/1ml loader
Rat IgG2a Negative Control:FITC MCA1212F F 100 Tests loader
Rat IgG2a Negative Control:Low Endotoxin MCA1212EL F 0.5 mg loader
Rat IgG2a Negative Control MCA1212 E F 1 ml loader
Rat IgG2a Negative Control:RPE MCA1212PE F 100 Tests loader
Rat IgG2a Negative Control:Alexa Fluor® 700 MCA1212A700 F 100 Tests/1ml loader

Useful Reagents Available

Description Product Code Applications Pack Size List Price Quantity
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Leucoperm BUF09 F 50 Tests
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Leucoperm BUF09 F 50 Tests
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Leucoperm BUF09 F 50 Tests
Leucoperm BUF09 F 50 Tests
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Antigen Retrieval Buffer, pH8.0 BUF025A P 500 ml
100x Antigen Retrieval Buffer, pH8.0 BUF025C P 50 ml
Leucoperm BUF09 F 50 Tests
Leucoperm BUF09 F 50 Tests
Antigen Retrieval Buffer, pH8.0 BUF025A P 500 ml
100x Antigen Retrieval Buffer, pH8.0 BUF025C P 50 ml
Leucoperm BUF09 F 50 Tests
Leucoperm BUF09 F 50 Tests
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Mouse Seroblock FcR BUF041A F 0.1 mg loader
Mouse Seroblock FcR BUF041B F 0.5 mg loader
Leucoperm BUF09 F 50 Tests

Application Based External Images

Flow Cytometry

Immunofluorescence

Immunohistology - Frozen

Immunohistology - Paraffin

Western Blotting

Product Specific References

Source Reference

  1. Smith, M. and Koch, G. (1987) Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes.
    J Cell Sci. 87:113-9.

References for CD68 antibody

  1. von Lukowicz, T. et al. (2008) PARP1 is required for adhesion molecule expression in atherogenesis.
    Cardiovasc Res. 78 (1): 158-66.
  2. Mortensen, M. et al. (2011) The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance.
    J Exp Med. 208: 455-67.
  3. Bacci, M. et al. (2009) Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease
    Am J Pathol. 175: 547-56.
  4. Baran, C.P. et al. (2007) Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.
    Am J Respir Crit Care Med. 176: 78-89.
  5. Chavele, K.M. et al. (2010) Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice.
    J Clin Invest. 120: 1469-78.
  6. Doyle, K.P. et al. (2010) TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke.
    J Neuroinflammation. 7: 62.
  7. Echeverry, A. et al. (2007) Murine neonates are highly resistant to Yersinia enterocolitica following orogastric exposure.
    Infect Immun. 75: 2234-43.
  8. Gräbner, R. et al. (2009) Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.
    J Exp Med. 206: 233-48.
  9. Kassim, S.H. et al. (2010) Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
    PLoS One. 5(10):e13424.
  10. Lebson, L. et al. (2010) Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice.
    J Neurosci. 30: 9651-8.
  11. Plüddemann, A. et al. (2009) The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia.
    PLoS Pathog. 5(2):e1000297.
  12. Yin, F. et al. (2010) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.
    J Exp Med. 207: 117-28.
  13. Giannattasio, G. et al. (2011) The purinergic g protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation.
    J Immunol. 187: 1486-95.
  14. Papadeas, S.T. et al. (2011) Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.
    Proc Natl Acad Sci U S A. 108: 17803-8.
  15. Sun, D. et al. (2008) Bone marrow-derived cell regulation of skeletal muscle regeneration.
    FASEB J. 23: 382-95.
  16. Douglas, G. et al. (2012) Endothelial-Specific Nox2 Overexpression Increases Vascular Superoxide and Macrophage Recruitment in ApoE-/- mice.
    Cardiovasc Res. 94: 20-9.
  17. Kyaw, T. et al. (2012) Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.
    PLoS One. 7: e29371.
  18. Nishiyama, K. et al. (2015) Mouse CD11b+ Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy.
    PLoS One. 10 (9): e0136774.
  19. Nakaya, M. et al. (2017) Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction.
    J Clin Invest. 127 (1): 383-401.
  20. Ramprasad, M.P. et al. (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein.
    Proc Natl Acad Sci U S A. 93 (25): 14833-8.
  21. Rabinowitz, S.S. & Gordon, S. (1991) Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli.
    J Exp Med. 174 (4): 827-36.
  22. da Silva, R.P. & Gordon, S. (1999) Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein.
    Biochem J. 338 ( Pt 3): 687-94.
  23. Schleicher, U. et al. (2005) Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-{gamma} in IL-12/IL-18-stimulated mouse macrophage populations.
    Blood 105: 1319-1328.
  24. Choi, E.J. et al. (2014) Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
    PLoS One. 9(2): e88511.
  25. Kassim, S. et al. (2010) Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
    PloS ONE 5: e13424.
  26. Rahaman, S.O. et al. (2011) Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation.
    J Biol Chem. 286: 7010-7.
  27. Frossard, J.L. et al. (2011) Role of CCL-2, CCR-2 and CCR-4 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury.
    J Clin Pathol. 64: 387-93
  28. West, E.L. et al. (2010) Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation.
    Stem Cells. 28: 1997-2007.
  29. Lopez, M.E. et al. (2011) Anatomically defined neuron-based rescue of neurodegenerative niemann-pick type C disorder.
    J Neurosci. 31: 4367-78.
  30. Jayagopal, A. et al. (2009) Quantum dot mediated imaging of atherosclerosis.
    Nanotechnology. 20: 165102.
  31. Leung, V.W. et al. (2009) Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Am J Pathol. 175: 1757-67.
  32. Devey, L. et al. (2009) Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism.
    Mol Ther. 17: 65-72.
  33. Lu, W. et al. (2010) Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres.
    Biomaterials. 31: 2617-26.
  34. de Beer, M.C. et al. (2003) Lack of a direct role for macrosialin in oxidized LDL metabolism.
    J Lipid Res. 44: 674-85.
  35. Song, L. et al. (2011) Deletion of the murine scavenger receptor CD68.
    J Lipid Res. 52: 1542-50.
  36. Daldrup-Link, H.E. et al. (2011) MR Imaging of Tumor Associated Macrophages with Clinically-Applicable Iron Oxide Nanoparticles.
    Clin Cancer Res. 17: 5695-704.
  37. Macauley, S.L. et al. (2011) The Role of Attenuated Astrocyte Activation in Infantile Neuronal Ceroid Lipofuscinosis
    J. Neurosci 31: 15575-85.
  38. Martin-Manso, G. et al. (2008) Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.
    Cancer Res. 68: 7090-9.
  39. Lazarini, F. et al. (2012) Early Activation of Microglia Triggers Long-Lasting Impairment of Adult Neurogenesis in the Olfactory Bulb
    J Neurosci 32: 3652-64
  40. Hemmi, H. et al. (2009) A new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cells.
    J Immunol. 182: 1278-86.
  41. Akbarshahi, H. et al. (2012) Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury.
    PLoS One. 7: e42654.
  42. Xiang, X. et al. (2016) TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.
    EMBO Mol Med. 8 (9): 992-1004.
  43. Masaki, T. et al. (2003) Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis.
    Nephrol. Dial. Transplant 18:178-81.
  44. Dormishian, M. et al. (2013) Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.
    J Am Heart Assoc. 2 (5): e000411.
  45. von Bargen, K. et al. (2014) Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections.
    PLoS One. 10 (4): e0121790.
  46. Hamour, S. et al. (2015) Local IL-17 Production Exerts a Protective Role in Murine Experimental Glomerulonephritis.
    PLoS One. 10 (8): e0136238.
  47. Wang L et al. (2016) Bone Fracture Pre-Ischemic Stroke Exacerbates Ischemic Cerebral Injury in Mice.
    PLoS One. 11 (4): e0153835.
  48. Nguyen, T.V. et al. (2016) Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue.
    Acta Neuropathol Commun. 4 (1): 100.
  49. Pena-Philippides, J.C. et al. (2016) In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response.
    J Neuroinflammation. 13 (1): 287.
  50. Paiva, A. A. et al. (2017) Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death.
    Oxidative Med Cellular Longev. 2017: 1-18.
  51. Giraldo, J.A. et al. (2016) The impact of cell surface PEGylation and short-course immunotherapy on islet graft survival in an allogeneic murine model.
    Acta Biomater. pii: S1742-7061(16)30656-0. [Epub ahead of print]
  52. Masuda, T. et al. (2017) Growth Factor Midkine Promotes Nuclear Factor of Activated T Cells-Regulated T-Cell-Activation and Th1 Cell Differentiation in Lupus Nephritis.
    Am J Pathol. Feb 6. pii: S0002-9440(17)30029-9. [Epub ahead of print]
  53. Garofalo, S. et al. (2017) The glycoside oleandrin reduces glioma growth with direct and indirect effects on tumor cells.
    J Neurosci. Mar 14. pii: 2296-16. [Epub ahead of print]
  54. Maeda, K. et al. (2017) Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.
    PLoS One. 12 (3): e0173706.
  55. Nishikawa, K. et al. (2015) Resveratrol increases CD68⁺ Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice.
    Mol Nutr Food Res. 59 (6): 1155-70.
  56. Nagy, B. et al. (2017) Different patterns of neuronal activity trigger distinct responses of oligodendrocyte precursor cells in the corpus callosum.
    PLoS Biol. 15 (8): e2001993.
  57. Koh, A.J. et al. (2017) The skeletal impact of the chemotherapeutic agent etoposide.
    Osteoporos Int. 28 (8): 2321-33.
  58. Menzies, R.I. et al. (2017) Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury.
    EBioMedicine. 19: 73-83.
  59. Takane, K. et al. (2017) Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure.
    J Am Heart Assoc. 6 (4)Apr 20 [Epub ahead of print].
  60. Xuan, H. et al. (2017) Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    J Vasc Surg. Apr 20 [Epub ahead of print].
  61. Metghalchi, S. et al. (2018) Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.
    PLoS One. 13 (3): e0193737.
  62. Hill, N.R. et al. (2018) RIPK3-deficient mice were not protected from nephrotoxic nephritis.
    BMC Nephrol. 19 (1): 61.
  63. Fumagalli, S. et al. (2019) The phagocytic state of brain myeloid cells after ischemia revealed by superresolution structured illumination microscopy.
    J Neuroinflammation. 16 (1): 9.
  64. Gratuze, M. et al.. (2020) Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration
    J Clin Invest130(9):4954-68.
  65. Garrett, M.C. et al. (2020) Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma.
    PLoS One. 15 (7): e0219632.
  66. Rahman, K. et al. (2017) Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.
    J Clin Invest. 127 (8): 2904-15.
  67. Santiago-Raber, M.L. et al. (2020) Atherosclerotic plaque vulnerability is increased in mouse model of lupus.
    Sci Rep. 10 (1): 18324.
  68. Zhang, X. et al. (2020) Targeted suppression of microRNA-33 in lesional macrophages using pH low-insertion peptides (pHLIP) improves atherosclerotic plaque regression
    Oct 28. [Epub ahead of print].
  69. Hada, Y. et al. (2020) Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice.
    Clin Sci (Lond). 134 (20): 2771-87.
  70. Souza, C.L.S.E. et al. (2020) Ovarian hormones influence immune response to Staphylococcus aureus infection.
    Braz J Infect Dis. Nov 10 [Epub ahead of print].
  71. Grundmann, S.M. et al. (2020) High-phosphorus diets reduce aortic lesions and cardiomyocyte size and modify lipid metabolism in Ldl receptor knockout mice.
    Sci Rep. 10 (1): 20748.
  72. Mia, M.M. et al. (2020) YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.
    PLoS Biol. 18 (12): e3000941.
  73. Zaghloul, N. et al. (2020) Prophylactic inhibition of NF-κB expression in microglia leads to attenuation of hypoxic ischemic injury of the immature brain.
    J Neuroinflammation. 17 (1): 365.
  74. Huang, J. et al. (2020) Bone Fracture Enhanced Blood-Brain Barrier Breakdown in the Hippocampus and White Matter Damage of Stroke Mice.
    Int J Mol Sci. 21 (22)Nov 11 [Epub ahead of print].
  75. Lowe, P.P. et al. (2020) Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations.
    J Neuroinflammation. 17 (1): 296.
  76. Stroobants, S. et al. (2020) Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction.
    Brain Pathol. : e12903.
  77. Alberti, S. et al. (2020) The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia.
    Sci Rep. 10 (1): 21420.
  78. Härdtner, C. et al. (2020) Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Basic Res Cardiol. 115 (6): 78.
  79. Ribeiro, P.C. et al. (2020) Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease.
    Stem Cell Res Ther. 11 (1): 530.
  80. Miró, L. et al. (2020) Dietary Supplementation with Spray-Dried Porcine Plasma Attenuates Colon Inflammation in a Genetic Mouse Model of Inflammatory Bowel Disease.
    Int J Mol Sci. 21(18): 6760.
  81. Zhou, F. et al. (2020) β-Carotene conversion to vitamin A delays atherosclerosis progression by decreasing hepatic lipid secretion in mice.
    J Lipid Res. 61 (11): 1491-1503.
  82. Nelvagal, H.R. et al. (2020) Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease.
    Sci Rep. 10 (1): 15157.
  83. Grubišić, V. et al. (2020) Enteric Glia Modulate Macrophage Phenotype and Visceral Sensitivity following Inflammation.
    Cell Rep. 32 (10): 108100.
  84. Riedl, K.A. et al. (2020) Wall shear stress analysis using 17.6 Tesla MRI: A longitudinal study in ApoE-/- mice with histological analysis.
    PLoS One. 15 (8): e0238112.
  85. Rojanathammanee, L. et al. (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.
    J Nutr. 143 (5): 597-605.
  86. Shahraz, A. et al. (2021) Phagocytosis-related NADPH oxidase 2 subunit gp91phox contributes to neurodegeneration after repeated systemic challenge with lipopolysaccharides.
    Glia. 69 (1): 137-50.
  87. Shi, Q. et al. (2021) Ultrasound-mediated blood-brain barrier disruption improves anti-pyroglutamate3 Aβ antibody efficacy and enhances phagocyte infiltration into brain in aged Alzheimer’s disease-like mice
    bioRxiv preprint: Jan 17 [Epub ahead of print].
  88. Alam, M.M. et al. (2021) Deficiency of microglial autophagy increases the density of oligodendrocytes and susceptibility to severe forms of seizures.
    eNeuro. Jan 14 [Epub ahead of print].
  89. Langin, L. et al. (2020) A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease.
    Sci Rep. 10 (1): 10591.
  90. Allen, B.D. et al. (2020) Mitigation of helium irradiation-induced brain injury by microglia depletion.
    J Neuroinflammation. 17 (1): 159.
  91. Drost, N. et al. (2020) The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin.
    Sci Rep. 10 (1): 7152.
  92. Vandestienne, M. et al. (2021) TREM-1 orchestrates angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm.
    J Clin Invest. 131 (2): e142468.
  93. Apodaca, L.A. et al. (2021) Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer's disease.
    Alzheimers Res Ther. 13 (1): 57.
  94. Colombo, A. et al. (2021) Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia.
    Nat Commun. 12 (1): 1158.
  95. Galle-Treger, L. et al. (2020) Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
    Cardiovasc Res. 116 (3): 554-565.
  96. Sun, Y. et al. (2008) Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient mice.
    BMC Neurosci. 9: 76.
  97. Miteva, K. et al. (2020) Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression.
    Sci Rep. 10 (1): 5791.
  98. El Gaamouch, F. et al. (2020) VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.
    Mol Neurodegener. 15 (1): 4.
  99. Chen, Y. et al. (2018) Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
    J Mol Med (Berl). 96 (12): 1359-73.
  100. Gökbuget, D. et al. (2018) The miRNA biogenesis pathway prevents inappropriate expression of injury response genes in developing and adult Schwann cells.
    Glia. 66 (12): 2632-2644.
  101. Papaneophytou, C.P. et al. (2018) Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Glia. 66 (12): 2589-603.
  102. Lim, S.L. et al. (2020) Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer's Disease-Like Neuropathology in Tg2576 Mice.
    Mol Neurobiol. 57 (5): 2447-60.
  103. Gajeton, J. et al. (2021) Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer.
    Cancers (Basel). 13(6):1346.
  104. Leipner, J. et al. (2021) Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe-/- mice.
    Mol Metab.May 12 : 101250 [Epub ahead of print].
  105. Shariq, M. et al. (2021) Adult neural stem cells have latent inflammatory potential that is kept suppressed by Tcf4 to facilitate adult neurogenesis.
    Sci Adv. 7 (21)May 21 [Epub ahead of print].
  106. Martínez-Beamonte, R. et al. (2021) Dietary Avian Proteins Are Comparable to Soybean Proteins on the Atherosclerosis Development and Fatty Liver Disease in Apoe-Deficient Mice
    Nutrients. 13 (6): 1838.
  107. Colombo, A.V. et al. (2021) Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition.
    Elife. 10:e59826.
  108. Ilyas, G. et al. (2019) Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.
    Alcohol Clin Exp Res. 43 (7): 1403-13.
  109. Riester, K. et al. (2020) In vivo. characterization of functional states of cortical microglia during peripheral inflammation.
    Brain Behav Immun. 87: 243-55.
  110. Yuan, C. et al. (2018) Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.
    Diabetes. 67 (9): 1880-91.
  111. Johnson, T.B. et al. (2019) Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water.
    Sci Rep. 9 (1): 14962.
  112. Kaji, N. et al. (2018) Disruption of the pacemaker activity of interstitial cells of Cajal via nitric oxide contributes to postoperative ileus.
    Neurogastroenterol Motil. Mar 15 [Epub ahead of print].
  113. Soto, I. et al. (2016) Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 42: 50-60.
  114. Wagner, M. et al. (2019) Clinical improvement and enhanced collateral vessel growth after xenogenic monocyte transplantation.
    Am J Transl Res. 11 (7): 4063-76.
  115. Zhang, Y. et al. (2019) Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT1R/ROS/p38 MAPK/ADAM17 pathway.
    Am J Physiol Cell Physiol. 317 (4): C776-C787.
  116. Guo, S.D. et al. (2019) Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
    CNS Neurosci Ther. 25 (6): 783-95.
  117. Säälik, P. et al. (2019) Peptide-guided nanoparticles for glioblastoma targeting.
    J Control Release. 308: 109-18.
  118. Welc, S.S. et al. (2019) Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy.
    Nat Commun. 10 (1): 2788.
  119. Matsumoto, K. et al. (2021) Juvenile social defeat stress exposure favors in later onset of irritable bowel syndrome-like symptoms in male mice.
    Sci Rep. 11 (1): 16276.
  120. Martínez-Beamonte, R. et al. (2021) Dietary Avian Proteins Are Comparable to Soybean Proteins on the Atherosclerosis Development and Fatty Liver Disease in Apoe-Deficient Mice.
    Nutrients. 13 (6):1838.
  121. Burgaz, S. et al. (2021) Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.
    Molecules. 26 (11): 3245.
  122. Stachowicz, A. et al. (2021) Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
    Int J Mol Sci. 22 (11): 5861
  123. Park, G.T. et al. (2021) Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
    Mar Drugs. 19 (5): 237.
  124. Götze, A.M. et al. (2020) IL10 Alters Peri-Collateral Macrophage Polarization and Hind-Limb Reperfusion in Mice after Femoral Artery Ligation.
    Int J Mol Sci. 21 (8): 2821.
  125. Flores, I. et al. (2021) Myeloid cell-mediated targeting of LIF to dystrophic muscle causes transient increases in muscle fiber lesions by disrupting the recruitment and dispersion of macrophages in muscle.
    Hum Mol Genet. Aug 14 [Epub ahead of print].
  126. Nakata, Y. et al. (2021) Role of podoplanin and Kupffer cells in liver injury after ischemia-reperfusion in mice.
    Surg Today. Sep 26 [Epub ahead of print].
  127. Cheah, F.C. et al. (2021) Studying the Effects of Granulocyte-Macrophage Colony-Stimulating Factor on Fetal Lung Macrophages During the Perinatal Period Using the Mouse Model.
    Front Pediatr. 9: 614209.
  128. Dorighello, G.G. et al. (2021) Mild Mitochondrial Uncoupling Decreases Experimental Atherosclerosis, A Proof of Concept.
    J Atheroscler Thromb. Jun 04 [Epub ahead of print].
  129. Wiśniewska, A. et al. (2021) Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo. Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio.
    Int J Mol Sci.22 (19): 10688.
  130. Bourel, J. et al. (2021) Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis
    Neurobiology of Disease. 160: 105533.
  131. Freeley, S.J. et al. (2021) The lectin pathway does not contribute to glomerular injury in the nephrotoxic nephritis model.
    Nephrology (Carlton). Oct 21 [Epub ahead of print].
  132. Schippers, M. et al. (2020) Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis.
    Cells. 9 (12): 2708.
  133. Härdtner, C. et al. (2020) Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Basic Res Cardiol. 115 (6): 78.
  134. Yeo, K.P. et al. (2020) Efficient aortic lymphatic drainage is necessary for atherosclerosis regression induced by ezetimibe.
    Sci Adv. 6 (50): eabc2697.
  135. Perez-Canamas, A. et al. (2021) Fronto-temporal dementia risk gene TMEM106B has opposing effects in different lysosomal storage disorders.
    Brain Commun. 3 (1): fcaa200.

Fluorescent Spectraviewer

Watch the Tool Tutorial Video ▸

How to Use the Spectraviewer

Watch the Tool Tutorial Video ▸
  • Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
  • Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
  • Select the lasers and filters you wish to include
  • Select combined or multi-laser view to visualize the spectra


Search for Batch Specific Datasheets


Flow Cytometry Workbook - Plan and improve your experiments


Free guide to become  an antibody expert


CiteAb logo - trusted, tested, published

Our CD68 (FA-11) Antibody has been referenced in >648 publications*


*Based on June 2020 data from CiteAb's antibody search engine.

Image gallery


Interactive tool: Immune cell and marker protein facts at your fingertips

All you need to know about immune cells, lineage, marker expression and the marker protein itself. Providing a direct link to antibodies available to your chosen marker.